ELISIO-H
Nipro Medical Corporation · Decision date Mar 19, 2026
What did the FDA decide?
FDA records K260533 as a 510(k) premarket notification, with a decision dated Mar 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Mar 19, 2026
Regulatory record facts
- Identifier
- K260533
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Nipro Medical Corporation
- Product code
- KDI
- Decision code
- SESE
- Decision date
- Mar 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dialyzer, High Permeability With Or Without Sealed Dialysate System.
- Applicant
- Nipro Medical Corporation
- Product code
- KDI
- FDA device class
- 2
FDA decision timeline
K260533 received
Application receipt date recorded by FDA.
K260533 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code KDI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
multiFiltratePRO SystemK261203 | Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Oct 19, 2026 | FDA |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Jul 24, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | May 15, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Feb 10, 2026 | FDA | |
| Outset Medical, Inc. | 510(k) clearance | Jan 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Nipro Medical Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Miami, FL
Sources and methodology
- Original FDA record: K260533
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



